(1-hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic acid monohydrate,
1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl)ethane-1,1-bisphosphonic acid monohydrate,
minodronate,
minodronic acid hydrate,
ONO-5920,
Phosphonic acid, (1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-,
YH 529,
YH-529,
YH529,
YM 529,
YM-529,
YM529,
155648-60-5,
Minodronic acid monohydrate,
(1-Hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl)diphosphonic acid hydrate,
minodronic acid hydrate,
UNII-457X74V7ND,
Minodronic acid hydrate [JAN],
457X74V7ND,
Minodronic acid hydrate (JAN),
Ono-5920,
Phosphonic acid, P,P'-(1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-, hydrate (1:1),
Minodronate hydrate,
Recalbon (TN),
Phosphonic acid, P,P'-(1-hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bis-, hydrate (1:1),
Bonoteo (TN),
MinodronateMonohydrate,
Minodronate Monohydrate,
SCHEMBL6009958,
DTXSID80165944,
BCP28470,
KS-000016NP,
CM0185,
AKOS022186525,
Phosphonic acid, (1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-, monohydrate,
AC-25762,
SC-83305,
FT-0689647,
ST24033506,
D09198,
(1-hydroxy-2-{imidazo[1,2-a]pyridin-3-yl}-1-phosphonoethyl)phosphonic acid hydrate,
(1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid;hydrate,
Minodronic acid,
Minodronate,
ACN-046379,
Minodronic acid hydrate, 99% - 1G 1g,
2663H,